THRD
Third Harmonic Bio Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$242.79M
P/E Ratio
—
EPS
$-1.24
Beta
2.13
52W High
$5.53
52W Low
$5.34
50-Day MA
$5.40
200-Day MA
$6.51
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Third Harmonic Bio Inc.
Third Harmonic Bio Inc. is a pioneering biotechnology firm focused on creating cutting-edge therapies for severe immunological and inflammatory disorders. Leveraging its proprietary genetic engineering platform, the company is developing a diverse pipeline of drug candidates that aim to fill substantial unmet medical needs in the biopharmaceutical landscape. With an unwavering commitment to scientific innovation and improving patient outcomes, Third Harmonic Bio is well-positioned to redefine treatment approaches and offer transformative solutions to challenges faced by patients and healthcare providers alike.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-64.25M |
| Operating Margin | 0.00% |
| Return on Equity | -19.90% |
| Return on Assets | -14.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $6.06 |
| Price-to-Book | 0.89 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -2.09 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $45.13M |
| Float | $15.60M |
| % Insiders | 9.11% |
| % Institutions | 80.12% |
Historical Volatility
HV 10-Day
0.00%
HV 20-Day
0.00%
HV 30-Day
0.00%
HV 60-Day
0.00%
HV Rank
76.2%
Volatility is currently contracting
More HEALTHCARE Stocks
Data last updated: 7/9/2026